Article Information
History
- September 25, 2020.
Article Versions
- Version 1 (August 7, 2020 - 09:54).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Roberto Pastor-Barriuso1,2,*,
- Beatriz Pérez-Gómez1,2,*,
- Miguel A Hernán3,
- Mayte Pérez-Olmeda4,
- Raquel Yotti5,
- Jesús Oteo-Iglesias4,6,
- Jose L Sanmartín7,
- Inmaculada León-Gómez1,2,
- Aurora Fernández-García2,4,
- Pablo Fernández-Navarro1,2,
- Israel Cruz8,
- Mariano Martín7,
- Concha Delgado-Sanz1,2,
- Nerea Fernández de Larrea1,2,
- Jose León Paniagua5,
- Juan F Muñoz-Montalvo7,
- Faustino Blanco7,
- Amparo Larrauri1,2,†,
- Marina Pollán1,2,#,† and
- on behalf of the ENE-COVID Study Group‡
- 1National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain
- 2Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain
- 3Departments of Epidemiology and Biostatistics, Harvard T.H. Chan School of Public Health; Harvard-MIT Division of Health Sciences and Technology, Boston, MA, USA
- 4National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain
- 5Institute of Health Carlos III, Madrid, Spain
- 6Spanish Network for Research in Infectious Diseases (REIPI), Institute of Health Carlos III, Madrid, Spain
- 7Ministry of Health, Madrid, Spain
- 8National School of Public Health, Institute of Health Carlos III, Madrid, Spain
- ↵*Correspondence to: Prof. Marina Pollán, National Centre for Epidemiology, Institute of Health Carlos III, Monforte de Lemos 5, 28029 Madrid, Spain. e-mail: mpollan{at}isciii.es
Posted September 25, 2020.
Infection fatality risk for SARS-CoV-2: a nationwide seroepidemiological study in the non-institutionalized population of Spain
